- Grants since 2016
- 113
- Awarded, last 5 years (where amounts are published)
- AUD 36M
- Funded works, last 5 years
- 761
- Funded works, all time
- 2 658
Grants
2025–2028 · research · 2024 Partnerships for Cancer Research grant program
Improving Bowel Cancer Care in Indigenous Population in Central Queensland: co-design, implementation, and evaluation of new models of care
2025–2028 · research · 2024 Partnerships for Cancer Research grant program
Sestaman: an Indigenous evaluation of the National Lung Cancer Screening Program
2025–2027 · research · 2023 Priority-driven Collaborative Cancer Research scheme
Tackling breast cancer growth and metastasis by suppressing ROCK-regulated paracrine signalling
2025–2028 · research · 2024 Partnerships for Cancer Research grant program
Towards an Indigenous Cancer Precision Medicine Platform
2025–2028 · research · 2024 Partnerships for Cancer Research grant program
SISTASCREEN – First Nations strength-based approaches to increasing cervical cancer screening in pregnancy and postpartum
2025–2028 · research · 2024 Partnerships for Cancer Research grant program
Empowering Indigenous Communities: Strengthening Agency, Equity, and Connections in Cancer Care and Prevention
2025–2028 · research · 2023 Priority-driven Collaborative Cancer Research scheme
The Skeleton: A Reservoir for Metastatic Outgrowth
2024–2027 · research · 2023 Priority-driven Collaborative Cancer Research scheme
Harnessing metabolic, genetic and protein biomarkers to predict neurotoxicity in taxane-treated cancer patients (NeuroTax): A prospective validation cohort study
2024–2027 · research · 2023 Priority-driven Collaborative Cancer Research scheme
Integrating cancer germline genetics, precision medicine and oncology to optimise management of paediatric AML
2024–2027 · research · 2023 Priority-driven Collaborative Cancer Research scheme
Taming free radicals to silence the epigenome of kinase active paediatric cancers
2024–2027 · research · 2023 Priority-driven Collaborative Cancer Research scheme
Unlocking the potential of the blood-brain barrier in the fight against paediatric brain gliomas
2024–2027 · research · 2023 Priority-driven Collaborative Cancer Research scheme
Harnessing the nucleolar stress response in cancer therapy
2024–2027 · research · 2023 Priority-driven Collaborative Cancer Research scheme
Taming free radicals to silence the epigenome of kinase active paediatric cancers
2024–2027 · research · 2023 Priority-driven Collaborative Cancer Research scheme
Exploiting cell-of-origin features to improve treatment for KEAP1-mutant lung cancer
2024–2027 · research · 2023 Priority-driven Collaborative Cancer Research scheme
Non-canonical PI3K targeting - novel therapies to exploit the lipid dependency of CLL
2024–2025 · research · 2023 Priority-driven Collaborative Cancer Research scheme
From relativity to respiration: How ideas from Einstein's general theory enable adaptative radiation therapy for lung cancer patients
2024–2025 · research · 2023 Priority-driven Collaborative Cancer Research scheme
Effect of co-occurring mutations on therapy response and resistance
The Council Of The Queensland Institute Of Medical Research
2024–2027 · research · 2023 Priority-driven Collaborative Cancer Research scheme
A novel hormonal therapy to treat lethal prostate cancer
2024–2025 · research · 2023 Priority-driven Collaborative Cancer Research scheme
Exercise as a novel therapeutic approach for sensitising prostate cancer to radiotherapy
2024–2027 · research · 2023 Priority-driven Collaborative Cancer Research scheme
Priming the blood-brain barrier to improve drug delivery and treatment outcomes in diffuse midline glioma
2024–2027 · research · 2023 Priority-driven Collaborative Cancer Research scheme
Insights from the functional tumour secretome: new opportunities to monitor and halt colorectal cancer progression
2024–2027 · research · 2023 Priority-driven Collaborative Cancer Research scheme
Treating chemoresistant ovarian cancer: Blocking follistatin signalling to enhance the effects of chemotherapy and prevent recurrence of chemoresistant disease
2024–2026 · research · 2023 Priority-driven Collaborative Cancer Research scheme
How are you breathing today?
2023–2027 · research · 2022 Priority-driven Collaborative Cancer Research Scheme (PdCCRS)
Linking routine health data to investigate variation and inequality in care and survival to improve outcomes for women with cervical, uterine, vaginal and vulvar cancer in Australia
The Council Of The Queensland Institute Of Medical Research (qimr Berghofer)
2023–2024 · research · 2022 Priority-driven Collaborative Cancer Research Scheme (PdCCRS)
Early detection, diagnosis, and prognosis of lung cancers
2023–2026 · research · 2022 Priority-driven Collaborative Cancer Research Scheme (PdCCRS)
Improving lung cancer care: the lung cancer clinical quality data platform (LUCAP)
2023–2025 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
Arming androgen receptors to transform endocrine therapy for ER+ breast cancer
2023–2025 · research · 2022 Priority-driven Collaborative Cancer Research Scheme (PdCCRS)
Radiomics analysis to improve outcomes for melanoma patients
2023–2026 · research · 2022 Priority-driven Collaborative Cancer Research Scheme (PdCCRS)
Targeting NAD metabolism to overcome therapeutic resistance in adult and paediatric acute myeloid leukaemia
2023–2026 · research · 2022 Priority-driven Collaborative Cancer Research Scheme (PdCCRS)
Boosting PSMA levels in prostate cancer
2023–2026 · research · 2022 Priority-driven Collaborative Cancer Research Scheme (PdCCRS)
Targeting the DC-T cell axis to treat glioblastoma
2023–2024 · research · 2022 Priority-driven Collaborative Cancer Research Scheme (PdCCRS)
The role of lipids in the immune fitness of malignant B cells, intratumoral T cells and CAR-T cells in follicular lymphoma
2023–2026 · research · 2022 Priority-driven Collaborative Cancer Research Scheme (PdCCRS)
REZOLV3R: Randomised trial of palliative intraperitoneal bevacizumab following therapeutic drainage of recurrent malignant ascites in patients with chemotherapy resistant solid tumours
2023–2025 · research · 2022 Priority-driven Collaborative Cancer Research Scheme (PdCCRS)
Targeting the CTHRC1-Wnt axis as a precision medicine approach in squamous lung cancer
2023–2025 · research · 2022 Priority-driven Collaborative Cancer Research Scheme (PdCCRS)
Targeted inhibition of myeloperoxidase (MPO): A new therapeutic strategy to prevent multiple myeloma disease progression
2023–2026 · research · 2022 Priority-driven Collaborative Cancer Research Scheme (PdCCRS)
Personalising first-line treatment for patients with metastatic colorectal cancer
2023–2026 · research · 2022 Priority-driven Collaborative Cancer Research Scheme (PdCCRS)
A novel probiotic as a preventive strategy for colorectal neoplasia
2022–2024 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
Applying artificial intelligence, epidemiological thinking and the perspectives of women and their radiologists to address the problem of dense breasts
2022–2025 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
nanoIMPAC: Monitoring immune toxicities and tumour immune evasion in lung cancer
2022–2024 · research · 2021 Priority-driven Collaborative Cancer Research Scheme